Medical Health Cluster

Variantes Covid

Anxiety in America: COVID ‘Takes a Backseat’ to Global Events 

With two years of COVID-19 in the rearview mirror, anxiety among US adults has turned instead toward global events, results from the annual Healthy Minds Poll from the American Psychiatric Association (APA) show. “It’s not surprising that recent events, such as the war in Ukraine, racially motivated mass shootings, or […]

Read More

Más del 75 por ciento de pacientes con covid persistente no fueron hospitalizados por su enfermedad inicial, según un estudio

Más de tres cuartas partes de los estadounidenses diagnosticados con COVID-19 persistente no presentaron gravedad suficiente para ser hospitalizados por su infección inicial, según informó el miércoles un nuevo análisis de decenas de miles de reclamaciones de seguros privados. El Times  Una selección semanal de historias en español que no encontrarás en ningún […]

Read More

Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021

Summary What is already known about this topic? As more persons are exposed to and infected by SARS-CoV-2, reports of patients who experience persistent symptoms or organ dysfunction after acute COVID-19 and develop post-COVID conditions have increased. What is added by this report? COVID-19 survivors have twice the risk for […]

Read More

Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019

Summary Background Human resources for health (HRH) include a range of occupations that aim to promote or improve human health. The UN Sustainable Development Goals (SDGs) and the WHO Health Workforce 2030 strategy have drawn attention to the importance of HRH for achieving policy priorities such as universal health coverage […]

Read More

Nucleocapsid Antibodies Appear to Be Long-Lasting After SARS-CoV-2 Infection

In a prospective, longitudinal study, N-antibodies peaked 90–100 days after infection and persisted for at least 500 days in most patients. The duration of antibody response after SARS-CoV-2 infection is not clearly established, although prior studies have estimated that antibodies produced after natural infection last from 3 to 6 months. […]

Read More

CRC Screening: Blood Test Accuracy Compared to Colonoscopy

The first prospective study to evaluate the accuracy of a blood test for people being screened for colorectal cancer (CRC) revealed a high sensitivity and specificity. At 90% specificity, the blood assay (Guardant Health) was 100% sensitive for detecting CRC. At 95% specificity, sensitivity was 88%. The blood assay detects circulating tumor […]

Read More

1 in 8 Develop Myocarditis Post COVID-19 Hospitalisation

In the largest study of its kind to date researchers have found that 1 in 8 people hospitalised with COVID-19 subsequently developed myocarditis, with the severity of infection most closely linked to the severity of long-COVID symptoms. For the new prospective cohort study, led by the University of Glasgow in […]

Read More

Estrogen Treatment Linked to Reduced COVID Mortality

Women who went on hormone replacement therapy (HRT) with estrogen within six months of catching COVID-19 had a reduced risk of dying, a new study says. The study, coupled with data showing men have higher hospitalization and mortality rates from COVID than women, provides more evidence that estrogen may offer broad protection against the […]

Read More